The time has come for pot growers who want to become one of the suppliers for New York’s medical marijuana program to put their name in the proverbial hat.
Earlier this week, the state’s Department of Health announced that it is officially in the process of accepting applications from those companies serious about cultivating medical marijuana for the patients of New York. The agency has set an application deadline of May 14, and licenses will be granted by sometime in July.
“This represents an important step in implementing the medical marijuana program in New York State,” Health Commissioner Howard Zucker said in a statement. “We have laid out an ambitious timeline in getting the program up and running, and we are meeting our goals. Once the applications are in, we can begin our review and move to the next step of selecting the registered organizations this summer.”
This lottery of sorts, which will only give a total of five companies permission to cultivate and distribute medical marijuana across the state, is expected to get rather interesting, especially since previous reports have indicated that hundreds of cannabis corporations from all over the United States will likely cast a bid. In fact, a story published at the beginning of the year by Capital New York suggested that lobbyists for many of these firms were already pressing the flesh with labor unions and other influential decision makers in an attempt to secure a place in the market before the state opened the application process.
However, companies chomping at the bit to get in on the medical marijuana market will need to provide officials with more than just suitcases full of cash to earn the right to call themselves one of the state’s cannabis kingpins. In addition to cleverly persuading local lawmakers to support them, applicants will need to present thorough proposals that indicate every aspect of their operation is tight.
“These applications are going to have to be very comprehensive in their approach to address all the requirements,” said Patrick McCarthy, a lobbyist representing KannaLife Sciences, Inc., a biopharmaceutical organization that is expected to be among the applicants.
For a chance to grow and sell medical marijuana in New York, applicants will be forced to cough up a $10,000 non-refundable application fee, as well as $200,000 for registration costs, which the health department says will be refunded to those companies that do not make the cut.
Applications can be obtained here.
Ontario Human Rights Commission Clarifies Laws on Working While Stoned
Canada’s Legal Cannabis May Pose Challenges for Police Dogs
The World’s Biggest Wine Buyer Dips into Cannabis in Canada
A Brand New Episode of ‘Canna Cribs’ Is Coming Soon
First Ever Trial to Study the Effects of Microdosing LSD Began This Month
What Do The Colors of Marijuana Mean?
Coca-Cola in Talks to Make the Next CBD-Infused Beverage
Canada Estimates $1 Billion in Legal Cannabis Sales in First Three Months
News7 days ago
A New Fingerprint Drug Testing System Can Detect With 99 Percent Accuracy
Business4 days ago
Walmart Joins List of Mega-Chains Considering New Marijuana Products
Legalization5 days ago
Want Cannabis to be Reclassified? Tell The Trump Administration
Sponsored6 days ago
Everything You Wanted to Know About CBD Tinctures
Medical Marijuana6 days ago
Riviera Creek Brings Science and Tech to Ohio’s New Medical Cannabis Market
Culture7 days ago
Here’s What You Need to Know to Throw a Lit Weed Wedding
Legalization7 days ago
Latest Polls Show 62 Percent of Americans Support Marijuana Legalization
News5 days ago
Denver’s Psilocybin Initiative Moves Forward to Signature Gathering Phase